Beyond Medical Technologies Inc. (DOCT.CN) Comparison with companies in other sectors?

Beyond Medical Technologies Inc. has a share price of 32.49M. You can analyze Beyond Medical Technologies Inc. (DOCT.CN) competitors across different market sectors through stock heatmaps.

What are DOCT.CN's NET and operating margins?

Beyond Medical Technologies Inc. (DOCT.CN) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does DOCT.CN's earnings per share (EPS) trend reflect its financial momentum?

Beyond Medical Technologies Inc. (DOCT.CN) EPS is 0.02 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Beyond Medical Technologies Inc. is 35.50, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Beyond Medical Technologies Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Beyond Medical Technologies Inc. like P/E which is -54.86, P/B which is -20.02, and PEG which is -1.66. Compare them with sector averages to evaluate if the stock is priced fairly.

Beyond Medical Technologies Inc.

DOCT.CN•CNQ

Industrials

Industrial - Pollution & Treatment Controls

CA$0.71

CA$-0.02(-2.74%)

Fundamental Analysis of Beyond Medical Technologies Inc. (DOCT.CN)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.02

P/E Ratio

35.50

ROE

0.46%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$23.07M

Shares OutstandingTotal number of shares issued

$32.49M

Book Value/ShareNet worth per share

$-0.04

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.02

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

45.87%

ROAReturn on total assets

-613.47%

ROCEReturn on capital employed

73.12%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.01

Cash/ShareCash and equivalents per share

$0.002

FCF YieldFree cash flow as percentage of market cap

-0.50%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for DOCT.CNFinancial Ratios Analysis details for DOCT.CN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for DOCT.CNSector Benchmarking details for DOCT.CN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Beyond Medical Technologies Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Beyond Medical Technologies Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Beyond Medical Technologies Inc.'s unique business strengths and challenges.

Key Financial Metrics for Beyond Medical Technologies Inc.

For Beyond Medical Technologies Inc., essential financial indicators include EPS 0.02, PE 35.50, and ROE 0.46. These key ratios reveal insights into Beyond Medical Technologies Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Beyond Medical Technologies Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Beyond Medical Technologies Inc.

Metrics like Net Margin - and ROA -613.47% shed light on how well Beyond Medical Technologies Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Beyond Medical Technologies Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Beyond Medical Technologies Inc.

Using ratios such as P/B Ratio -20.02 and PEG Ratio -1.66, investors can assess whether Beyond Medical Technologies Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Beyond Medical Technologies Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Beyond Medical Technologies Inc.

Financial health indicators, such as Debt/Equity Ratio -0.11 and Cash Flow $-0.01, provide a snapshot of Beyond Medical Technologies Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Beyond Medical Technologies Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Beyond Medical Technologies Inc.

Investing in Beyond Medical Technologies Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Beyond Medical Technologies Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;